Recurrent cardiovascular and limb events in 294,428 patients with coronary or peripheral artery disease or ischemic stroke on antiplatelet monotherapy: The RESRISK cohort study

Author
A. Vallejo-Vaz
K. Dharmayat
N. Nzeakor
C. Carrasco
S. Fatoba
M. Fonseca
E. Tolani
C. Lee
K. Ray
Keywords
Aspirin
Clopidogrel
Coronary heart disease
ischemic stroke
Peripheral heart disease
Platelet Aggregation inhibitors
Residual cardiovascular risk
Year of Publication
2024
Journal
Atherosclerosis
Volume
398
Number of Pages
118589
ISBN Number
0021-9150
Accession Number
39277962
DOI
10.1016/j.atherosclerosis.2024.118589